COMMUNIQUÉS West-GlobeNewswire

Medtronic Announces One-Month DAPT Clinical Study in the U.S. and Japan with Resolute Onyx DES in High Bleeding Risk Patients
10/09/2018
The Onyx ONE Clear Study Builds Upon Body of Clinical Evidence to Inform Individualized DAPT Duration Following Stent Procedures DUBLIN - September 10, 2018 - Medtronic plc (NYSE:MDT) today announced the start of the [...]
Cerner President Zane Burke to Step Down
10/09/2018
Quarterly and full-year guidance reaffirmed KANSAS CITY, Mo., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Cerner today announced that Zane Burke will step down as President of the company Nov. 2. “We thank Zane for his [...]
Transactions under Novozymes’ stock buyback program
10/09/2018
Please read the full announcement in the attached PDF Attachment 2018_53_Stock_Buybackprogram_EN
H1 To Incorporate Key Opinion Leader Data In Veeva CRM Platform
10/09/2018
H1 combined with Veeva CRM will help life sciences clients find the right influencers in minutes instead of months NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE) -- H1 , the first company to arm healthcare organizations with [...]
CCAB and Triumvira Immunologics Announce Triumvira’s License Agreement with University of Toronto for the Discovery of Antibody Drug Development Candidates
10/09/2018
AUSTIN, Texas and HAMILTON, Ontario and TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- The Centre for the Commercialization of Antibodies and Biologics (CCAB) and Triumvira Immunologics, Inc. (Triumvira), announced today a [...]
TRACON Pharmaceuticals Announces Publication of Phase 1b Results for TRC105 in Combination with Inlyta® in Patients with Advanced or Metastatic RCC
10/09/2018
Data Published in Peer-Reviewed Journal, The Oncologist SAN DIEGO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and [...]
Advantis Corp Reports 30% Revenue Rise, Set to Increase Oregon Production by 50%
10/09/2018
NEWPORT BEACH, CA, Sept. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Advantis Corporation (OTC PINK: ADVT) recently released the second quarter financials, posting a thirty percent rise in revenue. The report was [...]
Flexion Therapeutics Announces Publication of Phase 2 Diabetes Data in September Issue of Rheumatology
10/09/2018
Phase 2 data evaluating ZILRETTA ® ( triamcinolone acetonide extended-release injectable suspension) in patients with Type 2 diabetes demonstrated lower blood glucose levels following ZILRETTA injection compared to TAcs [...]
California’s Crucial Role in the Cannabis Retail Market -- CFN Media
10/09/2018
SEATTLE, Sept. 10, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
Results of interventional study support the use of suPARnostic® Quick Triage in emergency departments
10/09/2018
Press Release Birkerød, 10 September 2018 Today, at the 12 th European Congress of Emergency Medicine in Glasgow, data from the TRIAGE III study were presented, evidencing that use of suPARnostic® Quick Triage shortened [...]
SHIRE ANNOUNCES EARLY RESULTS OF THE PREVIOUSLY ANNOUNCED CASH TENDER OFFERS FOR CERTAIN OUTSTANDING NOTES
10/09/2018
SHIRE ANNOUNCES EARLY RESULTS OF THE PREVIOUSLY ANNOUNCED CASH TENDER OFFERS FOR CERTAIN OUTSTANDING NOTES Dublin, Ireland – September 10, 2018 –Shire plc (LSE: SHP and NASDAQ: SHPG) (“Shire”), Baxalta Incorporated, a [...]
Fluidigm Announces Co-Marketing Agreement with Visiopharm to Expand and Simplify Imaging Mass Cytometry Data Analysis
10/09/2018
Visiopharm Phenomap software presented at the Fluidigm Imaging Mass Cytometry User Group Meeting, expanding the suite of Hyperion Imaging System data analysis tools for translational and clinical research SOUTH SAN [...]
Yield10 Bioscience Researcher Dr. Meghna Malik to Present at the 26th CAOCS Canadian Lipid and Bioresource Conference 2018
10/09/2018
WOBURN, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today [...]
Sharps Compliance Announces That Montana Will Purchase Medication Disposal Kiosks Via Recently Awarded Partnership for Success Grant
10/09/2018
The Addictive and Mental Disorders Division (AMDD) of the Montana Department of Public Health and Human Services (DPHSS) plans to place 212 medication collection kiosks throughout the state HOUSTON, Sept. 10, 2018 ( [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
10/09/2018
Villepinte (France), le 10 septembre 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 [...]
Biodesix Pipeline Test Demonstrates Utility in Triaging Patients with Lung Nodules in New CHEST Data Publication
10/09/2018
Independent Study Data Shows Noninvasive Test Could Eliminate the Biopsy Needle, Lower Patient Anxiety and Costs BOULDER, Colo., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Biodesix today announced newly published data showing [...]
The American Health Council Names Norman Tomaka, BS, Pharm.MS, FAPhA to its Industry Board
10/09/2018
NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Norman Tomaka, BS, Pharm.MS, FAPhA is named to the American Health Council’s Industry Board. A clinical consultant pharmacist at Consultant Pharmacist Services in Melbourne, [...]
Progressive Care Announces Newly Redesigned Website for Wholly-Owned Subsidiary PharmCo, LLC
10/09/2018
PharmCo’s New Website to Bring More Focus on Robust Offering of Telepharmacy Products and Services MIAMI, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and [...]
Opiant Pharmaceuticals, Inc. and Consort Medical plc Announce Manufacturing Agreement for OPNT003, Intranasal Nalmefene, for Treatment of Opioid Overdose
10/09/2018
SANTA MONICA, Calif., and HEMEL HEMPSTEAD, United Kingdom, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing pharmacological [...]

Pages